Cary Pfeffer
Fondateur chez Casma Therapeutics, Inc.
Provenance du réseau au premier degré de Cary Pfeffer
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts.
120
| Private Company | Investment Managers | 120 |
| Extinct | Pharmaceuticals: Major | 28 | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.
24
| Subsidiary | Biotechnology | 24 |
| Subsidiary | Miscellaneous Commercial Services | 20 | |
| Subsidiary | Biotechnology | 15 | |
Rheos Medicines, Inc.
 Rheos Medicines, Inc. BiotechnologyHealth Technology Rheos Medicines, Inc. operates as a biopharmaceutical firm. It develops novel medicines that modulate metabolic pathways in immune cells to treat disease. The company was founded by Erika Pearce, Edward Pearce, Laurence Turka, Richard Flavell, Ken Smith, and E. William St. Clair and is headquartered in Cambridge, MA.
9
| Private Company | Biotechnology | 9 |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA.
9
| Subsidiary | Biotechnology | 9 |
Casma Therapeutics, Inc.
 Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Casma Therapeutics, Inc. operates biotechnology company harnessing natural cellular process of autophagy to design new medicines. The company was founded by Cary Pfeffer and is headquartered in Cambridge, MA.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Ablexis LLC
 Ablexis LLC Packaged SoftwareTechnology Services Ablexis LLC develops next-generation platform for antibody drug discovery. It develops the AlivaMab Mouse, an innovative, next-generation transgenic mouse platform intended to enable the efficient discovery and development of the next generation of human therapeutic antibodies. The company was founded by Green L. Larry and Hiroaki Shizuya in December 2009 and is headquartered in Burlingame, CA.
3
| Holding Company | Packaged Software | 3 |
Faze Medicines, Inc. /MA)
 Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Faze Medicines, Inc. provides medical services. The company is headquartered in San Francisco, CA.
1
| Extinct | Miscellaneous Commercial Services | 1 |
Third Rock Ventures GP LP
1
| Subsidiary | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Cary Pfeffer via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Director of Finance/CFO Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Graduate Degree Masters Business Admin Graduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| Stanford University | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| Boston University | College/University | Undergraduate Degree Graduate Degree Corporate Officer/Principal | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chairman Chief Tech/Sci/R&D Officer Chief Operating Officer Corporate Officer/Principal | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Founder Director/Board Member Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Brandeis University | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Director/Board Member Undergraduate Degree Graduate Degree Doctorate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member President Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| FOUNDATION MEDICINE INC | Medical/Nursing Services | Director/Board Member Founder Director/Board Member Chief Executive Officer Chief Executive Officer | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Chairman Founder Corporate Officer/Principal Director/Board Member | |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
| SERES THERAPEUTICS, INC. | Biotechnology | Founder Founder Director/Board Member | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO General Counsel | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member Director/Board Member | |
| PLIANT THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Ambys Medicines, Inc.
 Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Ambys Medicines, Inc. develops regenerative medicine therapies for serious liver diseases. The company was founded by Martin Burke, Markus Grompe, Juan Carlos Izpisua Belmonte and Holger Willenbring and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Chief Executive Officer | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
Thrive Earlier Detection Corp.
 Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Asher Biotherapeutics, Inc.
 Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Consultant / Advisor | |
AlivaMab Discovery Services LLC
 AlivaMab Discovery Services LLC BiotechnologyHealth Technology AlivaMab Discovery Services LLC is a private company that specializes in generating and screening large panels of antibodies to achieve their partners' design goals. AlivaMab Discovery Services is based in San Diego, CA. The company focuses on delivering antibodies that are characterized for function, kinetics, and developability, and engineering for advanced modalities, including multispecifics and cars. The company has experience in antibody drug discovery and development from many of the world's top pharmaceutical companies, including AbbVie, AstraZeneca, Bristol Myers Squibb, Novartis, Pfizer, and Roche/Genentech. The company was founded by John Lippincott, and the CEO is Larry L. Green. | Biotechnology | Chief Executive Officer Director/Board Member Founder | |
| TANGO THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member Director of Finance/CFO Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Chairman Director/Board Member Director/Board Member Consultant / Advisor | |
Abata Therapeutics, Inc.
 Abata Therapeutics, Inc. BiotechnologyHealth Technology Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer. | Biotechnology | Chairman Director/Board Member Private Equity Investor Founder Director/Board Member Consultant / Advisor | |
Septerna, Inc.
 Septerna, Inc. Pharmaceuticals: MajorHealth Technology Septerna, Inc. is a biotechnology company located in an undisclosed location. The American company is focused on developing novel, oral small molecule drugs that target the entire class of G protein-coupled receptors (GPCRs). The company's Native Complex™ platform allows for the rapid application of new technologies for industrial-scale drug discovery to address both validated GPCRs and many GPCRs that have been undruggable and unexploited to date. Septerna is building a pipeline of GPCR-targeted, oral small molecule drug candidates, led by its program targeting the parathyroid hormone 1 receptor (PTH1R) for the treatment of hypoparathyroidism. The company was founded in 2022 by scientific founders who have made groundbreaking GPCR discoveries, including Patrick Sexton, Arthur Christopoulos, Robert Joseph Lefkowitz, and Jeffrey T. Finer. Jeffrey T. Finer has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman Founder Chief Operating Officer |
Statistiques
Internationale
| Etats-Unis | 47 |
| Suisse | 3 |
| Royaume-Uni | 2 |
| Israël | 2 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 13 |
| Commercial Services | 6 |
| Health Services | 3 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 506 |
| Corporate Officer/Principal | 251 |
| Independent Dir/Board Member | 157 |
| Founder | 120 |
| Chairman | 114 |
Relations les plus connectées
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Steven Paul | 38 |
| Perry Karsen | 38 |
| Neil Exter | 33 |
| Daniel Lynch | 32 |
| David Berry | 31 |
| Charles Homcy | 28 |
| Stephen Sherwin | 26 |
| Mark Levin | 26 |
| Wendy Dixon | 25 |
| Mary Lynne Hedley | 25 |
| Alexis Borisy | 25 |
| Jane Henderson | 24 |
| Robert Tepper | 24 |
| Abbie Celniker | 23 |
- Bourse
- Insiders
- Cary Pfeffer
- Connexions Sociétés
